ROBERTSON, C.C, INSHAW, J.R.J, ONENGUT-GUMUSCU, S, CHEN, W-M, FLORES SANTA CRUZ, D, YANG, H , CUTLER, A,J, CROUCH, D.J.M, FARBER, E, BRIDGES S.L.JR, , EDBERG, J.C, KIMBERLY, R.P , BUCKNER, J.H, DELOUKAS, P, DIVERS, J, DABELEA, D, LAWRENCE, J.M, MARCOVINA, S, SHAH, A.S, GREENBAUM, C.J, ATKINSON, M.A, GREGERSEN, P.K, OKSENBERG, J.R, POCIOT, F, REWERS, M.J, STECK, A.K, DUNGER, D.B, the TYPE 1 DIABETES GENETICS CONSORTIUM, WICKER, L.S, CONCANNON, P, TODD, J.A and RICH, S.S.
(2021)
Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes.
Nature Genetics , 53, 962–971.